Creative Biolabs-Lipid Based Drug Delivery

Targeted Lipid Nanoparticle Products

Introduction Classification Applications Why Choose Us Related Services FAQs Resources Products

Welcome to the forefront of targeted drug delivery. At Creative Biolabs, we leverage decades of expertise in bioconjugation and nanomedicine to offer a comprehensive portfolio of Targeted Lipid Nanoparticle (LNP) products. These advanced delivery systems are engineered to overcome the limitations of conventional therapeutics, providing unprecedented precision, efficacy, and safety in targeting specific cells and tissues.

What are Targeted Lipid Nanoparticles (LNPs)?

Lipid Nanoparticles (LNPs) have revolutionized the field of drug delivery, most notably in their role as the enabling technology for mRNA vaccines. LNPs are nanoscale spherical vesicles composed of ionizable lipids, structural lipids, cholesterol, and PEGylated lipids. They encapsulate and protect fragile therapeutic payloads, such as nucleic acids (mRNA, siRNA, DNA) or small molecules, facilitating their cellular uptake and endosomal escape.

Targeted LNPs elevate this technology by incorporating specific targeting ligands onto their surface. These ligands—which can be antibodies, peptides, aptamers, or small molecules—recognize and bind to distinct receptors overexpressed on the surface of target cells (e.g., tumor cells, specific immune cells, or hepatocytes). This active targeting mechanism ensures that the therapeutic payload is delivered precisely to the intended site of action, minimizing systemic toxicity and maximizing therapeutic impact.

Fig.1 Surface Modification and Applications of Targeted LNP. (Creative Biolabs Original)Fig.1 Surface-Modified Lipid Nanoparticles for Targeted Delivery.

Classification and Advantages of Targeted LNPs

Our targeted LNP portfolio is categorized based on the specific surface modification strategy, allowing you to select the optimal platform for your research or development needs.

Targeting Strategy Mechanism of Action Key Advantages
Antibody-Modified LNPs (Immuno-LNPs) Monoclonal antibodies or antibody fragments (scFv, Fab) are conjugated to the LNP surface, offering high affinity and specificity for corresponding cellular antigens. Exceptional targeting precision; ideal for complex antigens; high stability; well-established conjugation chemistries.
Peptide-Modified LNPs Short targeting peptides are utilized to bind specific cellular receptors (e.g., integrins, transferrin receptors). Smaller ligand size minimizes steric hindrance; lower immunogenicity; cost-effective synthesis; tunable binding affinity.
Small Molecule-Modified LNPs Ligands such as folate, carbohydrates (e.g., GalNAc), or specific vitamins are used to target receptors highly expressed on certain tissues (e.g., liver, activated macrophages). Excellent tissue penetration; low manufacturing cost; highly defined structures; proven clinical efficacy (e.g., GalNAc for hepatic delivery).

Applications of Targeted LNP Therapeutics

Targeted LNPs are driving innovation across a broad spectrum of biomedical applications:

Precision Oncology

Delivering siRNAs to silence oncogenes, mRNAs to encode tumor-suppressor proteins, or chemotherapeutics directly to the tumor microenvironment, minimizing off-target effects and overcoming drug resistance.

Gene Editing

Targeted delivery of CRISPR-Cas9 components (mRNA for Cas9 and sgRNA) to specific tissues for the treatment of genetic disorders.

Immunotherapy

Engineering immune cells in vivo by delivering specific antigens or immune-modulating agents directly to dendritic cells or T cells.

Hepatic Diseases

Leveraging natural or engineered targeting (like GalNAc) for the highly efficient delivery of therapeutics to hepatocytes for metabolic and viral liver diseases.

Neurological Disorders

Developing surface modifications designed to facilitate transport across the blood-brain barrier (BBB) for targeted treatment of neurodegenerative diseases.

Why Choose Creative Biolabs for Your Targeted LNP Needs?

As your dedicated partner in nanomedicine development, Creative Biolabs offers distinct advantages:

  • Decades of Specialized Expertise: With over 20 years of experience in bioconjugation and nanocarrier design, our scientific team possesses unparalleled knowledge in optimizing targeted delivery systems.
  • Proprietary Conjugation Technologies: We utilize advanced, highly efficient, and reproducible conjugation chemistries that preserve ligand functionality and LNP integrity during the modification process.
  • Stringent Quality Control: All our targeted LNP products undergo rigorous characterization—including particle size, zeta potential, encapsulation efficiency, ligand density, and stability analysis—ensuring consistent, high-quality performance.
  • Comprehensive Customization: We understand that every project is unique. We provide unparalleled flexibility, offering a vast selection of lipids, payloads, and targeting ligands to meet your precise specifications.

Beyond our extensive catalog of off-the-shelf formulations, our capabilities extend to fully bespoke LNP solutions. We provide advanced custom conjugation services, enabling the precise modification of LNPs with your specific targeting ligands, including specialized antibodies, unique peptides, and small molecules. Furthermore, our expert team can seamlessly engineer and manufacture custom LNPs conjugated with your exact desired clone, ensuring optimal targeting and experimental continuity.

Related Services

Creative Biolabs is more than a product supplier; we are your strategic development partner. To accelerate your research from concept to preclinical validation, we offer a comprehensive suite of customized nanomedicine services.

FAQs

What types of payloads can be encapsulated in your targeted LNPs?

We can formulate targeted LNPs encapsulating a wide variety of payloads, including mRNA, siRNA, pDNA, oligonucleotides, peptides, proteins, and small molecule drugs.

Can I provide my own proprietary targeting ligand for LNP modification?

Yes. Through our custom formulation services, we can successfully conjugate client-provided antibodies, peptides, or other proprietary molecules onto our optimized LNP platforms.

What scale of LNP production do you support?

We support projects at all stages, from milligram-scale formulations for early proof-of-concept studies to larger-scale production for advanced preclinical research.

Do you offer downstream in vitro and in vivo testing services for the formulated targeted LNPs?

Absolutely. We recognize that formulation is only the first step. To support your full development pipeline, Creative Biolabs provides comprehensive downstream evaluation services. We can perform rigorous in vitro assays to validate cellular uptake, targeting specificity, and payload expression/silencing in your chosen cell lines. Furthermore, our experienced in vivo pharmacology team can conduct animal studies to assess the biodistribution, pharmacokinetic profile, and therapeutic efficacy of your customized targeted LNPs in relevant disease models.

Resources

Products

 

For Research Use Only. Not For Clinical Use

Products

Liposomes Lipid Nanoparticles
Lipids Kits

Online Inquiry